BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20510065)

  • 1. [Study on the status of cognition among Parkinson's disease patients in Xi'an.].
    Wang RL; Qu QM; Cao HM; Zhe X; Qiao J; Guo F
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Mar; 31(3):329-32. PubMed ID: 20510065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study of psychometric properties of the Beijing version of Montreal Cognitive Assessment in patients with idiopathic Parkinson's disease in China.
    Nie K; Zhang Y; Wang L; Zhao J; Huang Z; Gan R; Li S; Wang L
    J Clin Neurosci; 2012 Nov; 19(11):1497-500. PubMed ID: 22959678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive deterioration rates in patients with Parkinson's disease from northeastern China.
    Luo XG; Feng Y; Liu R; Yu HM; Wang L; Wu Z; Ren Y; He ZY
    Dement Geriatr Cogn Disord; 2010; 30(1):64-70. PubMed ID: 20689285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes on brief cognitive instruments over time in Parkinson's disease.
    Lessig S; Nie D; Xu R; Corey-Bloom J
    Mov Disord; 2012 Aug; 27(9):1125-8. PubMed ID: 22692724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease.
    Zadikoff C; Fox SH; Tang-Wai DF; Thomsen T; de Bie RM; Wadia P; Miyasaki J; Duff-Canning S; Lang AE; Marras C
    Mov Disord; 2008 Jan; 23(2):297-9. PubMed ID: 18044697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based case-control study of cognitive function in early Parkinson's disease (NEDICES).
    Benito-León J; Louis ED; Posada IJ; Sánchez-Ferro Á; Trincado R; Villarejo A; Mitchell AJ; Bermejo-Pareja F
    J Neurol Sci; 2011 Nov; 310(1-2):176-82. PubMed ID: 21774946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive dysfunction in Nigerians with Parkinson's disease.
    Akinyemi RO; Okubadejo NN; Akinyemi JO; Owolabi MO; Owolabi LF; Ogunniyi A
    Mov Disord; 2008 Jul; 23(10):1378-83. PubMed ID: 18546341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: a randomized, double-blind, placebo-controlled, multicenter study.
    Hanagasi HA; Gurvit H; Unsalan P; Horozoglu H; Tuncer N; Feyzioglu A; Gunal DI; Yener GG; Cakmur R; Sahin HA; Emre M
    Mov Disord; 2011 Aug; 26(10):1851-8. PubMed ID: 21500280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive impairment patterns in Parkinson's disease with visual hallucinations.
    Ozer F; Meral H; Hanoglu L; Ozturk O; Aydemir T; Cetin S; Atmaca B; Tiras R
    J Clin Neurosci; 2007 Aug; 14(8):742-6. PubMed ID: 17544275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive profile of patients with newly diagnosed Parkinson disease.
    Muslimovic D; Post B; Speelman JD; Schmand B
    Neurology; 2005 Oct; 65(8):1239-45. PubMed ID: 16247051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of leukoaraiosis on the cognition of patients with Parkinson disease].
    Wang L; Zhu XQ; Jiang CJ; Chen XW; Sun ZW
    Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(3):177-81. PubMed ID: 23570589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease.
    Heo JH; Lee KM; Paek SH; Kim MJ; Lee JY; Kim JY; Cho SY; Lim YH; Kim MR; Jeong SY; Jeon BS
    J Neurol Sci; 2008 Oct; 273(1-2):19-24. PubMed ID: 18640690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of montreal cognitive assessment between patients with visual hallucinations and without visual hallucinations in Parkinson's disease.
    Chung EJ; Seok K; Kim SJ
    Clin Neurol Neurosurg; 2015 Mar; 130():98-100. PubMed ID: 25596487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment in Parkinson's disease without dementia.
    Rodríguez-Ferreiro J; Cuetos F; Herrera E; Menéndez M; Ribacoba R
    Mov Disord; 2010 Oct; 25(13):2136-41. PubMed ID: 20725913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brief cognitive assessment in the early stages of Parkinson disease.
    Bugalho P; Vale J
    Cogn Behav Neurol; 2011 Dec; 24(4):169-73. PubMed ID: 22045168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Age-related working memory decline in patients with Parkinson's disease].
    Tamura I; Kikuchi S; Kitagawa M; Otsuki M; Tashiro K
    No To Shinkei; 2003 Apr; 55(4):335-40. PubMed ID: 12755037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cognition deterioration in Parkinson's disease: associated risk factors].
    Errea JM; Ara JR
    Rev Neurol; 1999 Mar 1-15; 28(5):439-43. PubMed ID: 10229953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility and limitations of Addenbrooke's Cognitive Examination-Revised for detecting mild cognitive impairment in Parkinson's disease.
    Komadina NC; Terpening Z; Huang Y; Halliday GM; Naismith SL; Lewis SJ
    Dement Geriatr Cogn Disord; 2011; 31(5):349-57. PubMed ID: 21613789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.